157 related articles for article (PubMed ID: 19502615)
21. [Surgical treatment of primary adenocarcinoma of the esophagus].
Chen YH
Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):371-3. PubMed ID: 2276332
[TBL] [Abstract][Full Text] [Related]
22. Comment on "The role of laparoscopy in preoperative staging of esophageal cancer".
Stein HJ; Feussner H
Surg Endosc; 2001 May; 15(5):528-9. PubMed ID: 11353981
[No Abstract] [Full Text] [Related]
23. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
[TBL] [Abstract][Full Text] [Related]
24. Lymphovascular invasion of tumor cells in lymph node metastases has a negative impact on survival in esophageal cancer.
Schiefer AI; Schoppmann SF; Birner P
Surgery; 2016 Aug; 160(2):331-40. PubMed ID: 27085684
[TBL] [Abstract][Full Text] [Related]
25. Changes in the surgical management of esophageal cancer from 1970 to 1993.
Swisher SG; Hunt KK; Holmes EC; Zinner MJ; McFadden DW
Am J Surg; 1995 Jun; 169(6):609-14. PubMed ID: 7771626
[TBL] [Abstract][Full Text] [Related]
26. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world.
Siewert JR; Stein HJ; Feith M; Bruecher BL; Bartels H; Fink U
Ann Surg; 2001 Sep; 234(3):360-7; discussion 368-9. PubMed ID: 11524589
[TBL] [Abstract][Full Text] [Related]
27. Does lymphadenectomy add anything to the treatment of esophageal cancer?
Law S; Wong J
Adv Surg; 1999; 33():311-27. PubMed ID: 10572574
[No Abstract] [Full Text] [Related]
28. Staging of oesophageal adenocarcinoma.
Hardwick RH; Williams GT
Br J Surg; 2002 Sep; 89(9):1076-7. PubMed ID: 12190670
[No Abstract] [Full Text] [Related]
29. Refining esophageal cancer staging.
Rice TW; Blackstone EH; Rybicki LA; Adelstein DJ; Murthy SC; DeCamp MM; Goldblum JR
J Thorac Cardiovasc Surg; 2003 May; 125(5):1103-13. PubMed ID: 12771884
[TBL] [Abstract][Full Text] [Related]
30. Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy.
Dittrick GW; Weber JM; Shridhar R; Hoffe S; Melis M; Almhanna K; Barthel J; McLoughlin J; Karl RC; Meredith KL
Ann Surg Oncol; 2012 May; 19(5):1678-84. PubMed ID: 22045465
[TBL] [Abstract][Full Text] [Related]
31. Increasing tumor length is associated with regional lymph node metastases and decreased survival in esophageal cancer.
Haisley KR; Hart KD; Fischer LE; Kunio NR; Bakis G; Tieu BH; Schipper PH; Sheppard BC; Hunter JG; Dolan JP
Am J Surg; 2016 May; 211(5):860-6. PubMed ID: 26993752
[TBL] [Abstract][Full Text] [Related]
32. Minimally invasive staging for esophageal cancer.
Krasna MJ
Chest; 1997 Oct; 112(4 Suppl):191S-194S. PubMed ID: 9337286
[TBL] [Abstract][Full Text] [Related]
33. A Multi-Institutional Study Comparing the Use of the American Joint Committee on Cancer 7th Edition Esophageal
Adeshuko FA; Squires MH; Poultsides G; Pawlik TM; Weber SM; Schmidt C; Votanopoulos K; Fields RC; Maithel SK; Cardona K
Am Surg; 2017 Jan; 83(1):82-89. PubMed ID: 28234131
[TBL] [Abstract][Full Text] [Related]
34. An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China.
Yang HX; Xu Y; Fu JH; Wang JY; Lin P; Rong TH
Ann Surg Oncol; 2010 Jul; 17(7):1901-11. PubMed ID: 20146101
[TBL] [Abstract][Full Text] [Related]
35. Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma.
Kelty CJ; Kennedy CW; Falk GL
J Thorac Oncol; 2010 Sep; 5(9):1467-71. PubMed ID: 20812404
[TBL] [Abstract][Full Text] [Related]
36. Evaluating the eighth edition TNM staging system for esophageal cancer among patients receiving neoadjuvant therapy: A SEER study.
Yuan Y; Ma G; Hu X; Huang Q
Cancer Med; 2020 Jul; 9(13):4648-4655. PubMed ID: 32391623
[TBL] [Abstract][Full Text] [Related]
37. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
[TBL] [Abstract][Full Text] [Related]
38. Individualized, multimodal palliative treatment of inoperable esophageal cancer: clinical impact of photodynamic therapy resulting in prolonged survival.
Lindenmann J; Matzi V; Neuboeck N; Anegg U; Baumgartner E; Maier A; Smolle J; Smolle-Juettner FM
Lasers Surg Med; 2012 Mar; 44(3):189-98. PubMed ID: 22334351
[TBL] [Abstract][Full Text] [Related]
39. Feasibility study of sentinel lymph node biopsy in esophageal cancer with conservative lymphadenectomy.
Thompson SK; Bartholomeusz D; Devitt PG; Lamb PJ; Ruszkiewicz AR; Jamieson GG
Surg Endosc; 2011 Mar; 25(3):817-25. PubMed ID: 20725748
[TBL] [Abstract][Full Text] [Related]
40. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
